Immune gene prognosis model for predicting hepatocellular carcinoma tumor immune infiltration and postoperative survival time

A technology of hepatocellular carcinoma and survival time, which is applied in the field of biomedicine, can solve problems that need to be developed and researched, and achieve the effect of improving the value of prognosis evaluation, prediction effect and postoperative survival rate
CN112011616AActive Publication Date: 2020-12-01上海顿慧医疗科技发展有限公司
5 Cites 37 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
上海顿慧医疗科技发展有限公司
Publication Date
2020-12-01

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to an immune gene prognosis model for predicting hepatocellular carcinoma tumor immune infiltration and postoperative survival time, and belongs to the technical field of biological medicines. The model can be used for evaluating the infiltration degree of immune cells in a tumor in clinical practice by detecting the expression levels of 22 specific immune related genes of ahepatocellular carcinoma patient, so that the model can be used for predicting hepatocellular carcinoma tumor immune infiltration in clinical practice and improve the prediction capability of the liver cancer immunotherapy response. The model can be used for judging the postoperative overall survival risk of a patient and guiding the formulation of a postoperative treatment strategy, and the corresponding microarray chip kit can realize the standardization and convenience of detection. Meanwhile, the immune gene prognosis model provided by the invention can increase the prediction accuracy andthe clinical net income of a hepatocellular carcinoma TNM staging system on the total survival time of three years and five years after operation. As a molecular marker for objectively and accuratelyevaluating the tumor immune state and poor prognosis risk of hepatocellular carcinoma, the model can realize accurate implementation of hepatocellular carcinoma immunotherapy and accurate prognosis prediction.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to an immune gene prognostic model for predicting tumor immune infiltration and postoperative survival time of hepatocellular carcinoma, belonging to the technical field of biomedicine. Background technique

[0002] Due to the associated chronic liver disease epidemic caused by viral infections and metabolic disturbances, the global incidence of HCC continues to increase, reaching 2%-3% per year, the fastest growing rate among all tumors. According to the latest national cancer statistics from the National Cancer Center of my country, the incidence of liver cancer ranks fourth, accounting for the fifth cause of cancer-related deaths, with approximately 326,000 deaths per year. Frequent recurrence after curative treatment in early patients and limited efficacy after systemic treatment in advanced patients lead to poor prognosis of HCC, with a 5-year survival rate of only 18%. However, there is currently a lack of effective and rel...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More